These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37209799)

  • 1. Effect of Early Amiodarone Use on Warfarin Sensitivity, Blood Product Use, and Bleeding in Patients With a Left Ventricular Assist Device.
    Thai SQ; Herrington TC; Baetz BE; Jennings KA; Lackie ML; Bukovskaya Y; Velasco-Gonzalez C; Desai SV; Krim SR
    Curr Probl Cardiol; 2023 Oct; 48(10):101801. PubMed ID: 37209799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
    Holm J; Lindh JD; Andersson ML; Mannheimer B
    J Thromb Haemost; 2017 Mar; 15(3):446-453. PubMed ID: 28058824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term drug interaction of warfarin with amiodarone].
    Hirmerová J; Suchý D; Mádr T
    Cas Lek Cesk; 2003 Jan; 142(1):39-42. PubMed ID: 12693297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage.
    Cicci CD; Weiss A; Dang C; Stanton M; Feldman R
    Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.
    Lam J; Gomes T; Juurlink DN; Mamdani MM; Pullenayegum EM; Kearon C; Spencer FA; Paterson M; Zheng H; Holbrook AM
    Am J Cardiol; 2013 Aug; 112(3):420-3. PubMed ID: 23664078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
    Miano TA; Yang W; Shashaty MGS; Zuppa A; Brown JR; Hennessy S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1446-1456. PubMed ID: 32112562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous use of amiodarone influences warfarin maintenance dose but is not associated with adverse events.
    Santos PC; Soares RA; Strunz CM; Grinberg M; Ferreira JF; Cesar LA; Scanavacca M; Krieger JE; Pereira AC
    J Manag Care Spec Pharm; 2014 Apr; 20(4):376-81. PubMed ID: 24684642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices.
    Brown CS; Zemrak WR; Dyer KJ; Rolfe S
    ASAIO J; 2019 Feb; 65(2):e21-e24. PubMed ID: 29561270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin.
    Avendano R; Romero J; Lupercio F; Diaz JC; Quispe R; Golive A; Natale A; Garcia MJ; Krumerman AK; Di Biase L
    J Interv Card Electrophysiol; 2019 Jan; 54(1):73-80. PubMed ID: 30128801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
    Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of prothrombin complex concentrate as a warfarin reversal agent in pediatric patients undergoing orthotopic heart transplantation.
    Sisti DJ; Williams GD; Ding V; Long J; Maeda K; Chen S; Navaratnam M
    Paediatr Anaesth; 2020 May; 30(5):564-570. PubMed ID: 32037665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple Antithrombotic Therapy in Patients With Left Ventricular Assist Devices.
    Krim SR; Bennett A; Pfeffer M; Campbell PT; Thai S; Baetz B; Wever-Pinzon J; Eiswirth C; Desai S; Ventura HO
    Curr Probl Cardiol; 2022 Aug; 47(8):100940. PubMed ID: 34384617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate.
    Kjerengtroen S; Chauv S; Hickman AW; Collingridge DS; Fontaine GV
    J Thromb Thrombolysis; 2022 Aug; 54(2):268-275. PubMed ID: 35378715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Prophylactic Amiodarone After Left Ventricular Assist Device.
    Graboyes SDT; Kline TM; Harris TN; Iyer PS; Hollis IB
    ASAIO J; 2023 Jan; 69(1):96-100. PubMed ID: 36583775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.
    Xia X; Fu J; Wu T; Chen W; Jiang S; Lv M; Zhang J
    Eur J Clin Pharmacol; 2022 Feb; 78(2):205-214. PubMed ID: 34596727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.
    Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA
    Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
    Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring may need to be prolonged in patients given warfarin and amiodarone.
    Tomlinson B; Young RP; Chan TY; Critchley JA; Chan JC
    BMJ; 1996 Aug; 313(7052):301-2. PubMed ID: 8704564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.